These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9265505

  • 1. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
    Tsuchiyama L, Kieran J, Boyle P, Wetzel GD.
    Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
    [Abstract] [Full Text] [Related]

  • 2. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF, Goldmacher VS, Lambert JM, Schlossman SF.
    J Immunol; 1986 Aug 15; 137(4):1387-91. PubMed ID: 3016095
    [Abstract] [Full Text] [Related]

  • 3. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR, McNaughton ME, Cooper NR.
    J Immunol; 1985 Nov 15; 135(5):3068-73. PubMed ID: 2995485
    [Abstract] [Full Text] [Related]

  • 4. CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells.
    Kwekkeboom J, De Boer M, Tager JM, De Groot C.
    Immunology; 1993 Jul 15; 79(3):439-44. PubMed ID: 7691726
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
    Ehlin-Henriksson B, Mowafi F, Klein G, Nilsson A.
    Immunology; 2006 Mar 15; 117(3):379-85. PubMed ID: 16476057
    [Abstract] [Full Text] [Related]

  • 6. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
    Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF.
    J Immunol; 1992 Nov 01; 149(9):2841-50. PubMed ID: 1383329
    [Abstract] [Full Text] [Related]

  • 7. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
    Luxembourg AT, Cooper NR.
    J Immunol; 1994 Nov 15; 153(10):4448-57. PubMed ID: 7525704
    [Abstract] [Full Text] [Related]

  • 8. Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner.
    Kim YS, Park GB, Choi YM, Kwon OS, Song HK, Kang JS, Kim YI, Lee WJ, Hur DY.
    Hum Immunol; 2006 Oct 15; 67(10):795-807. PubMed ID: 17055356
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S.
    Hokkaido Igaku Zasshi; 1985 Sep 15; 60(5):724-34. PubMed ID: 3000906
    [Abstract] [Full Text] [Related]

  • 10. Immortalization of EBV-infected B cells is not influenced by exogenous signals acting on B cell proliferation. Effects of mutant EL-4 thymoma cells and transforming growth factor-beta.
    Straub C, Zubler RH.
    J Immunol; 1989 Jan 01; 142(1):87-93. PubMed ID: 2535862
    [Abstract] [Full Text] [Related]

  • 11. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction.
    Masucci MG, Szigeti R, Ernberg I, Hu CP, Torsteinsdottir S, Frade R, Klein E.
    Eur J Immunol; 1987 Jun 01; 17(6):815-20. PubMed ID: 3036539
    [Abstract] [Full Text] [Related]

  • 12. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
    Tosato G, Blaese RM, Yarchoan R.
    J Immunol; 1985 Aug 01; 135(2):959-64. PubMed ID: 2989369
    [Abstract] [Full Text] [Related]

  • 13. Activation and infection of B cells by Epstein-Barr virus. Role of calcium mobilization and of protein kinase C translocation.
    Dugas B, Delfraissy JF, Calenda A, Peuchmaur M, Wallon C, Rannou MT, Galanaud P.
    J Immunol; 1988 Dec 15; 141(12):4344-51. PubMed ID: 2848895
    [Abstract] [Full Text] [Related]

  • 14. B-cell-derived IL-10: production and function.
    Burdin N, Rousset F, Banchereau J.
    Methods; 1997 Jan 15; 11(1):98-111. PubMed ID: 8990095
    [Abstract] [Full Text] [Related]

  • 15. B cell activation leads to shedding of complement receptor type II (CR2/CD21).
    Masilamani M, Kassahn D, Mikkat S, Glocker MO, Illges H.
    Eur J Immunol; 2003 Sep 15; 33(9):2391-7. PubMed ID: 12938215
    [Abstract] [Full Text] [Related]

  • 16. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
    Pernegger G, Schulz TF, Hosp M, Myones BL, Petzer AL, Eigentler A, Böck G, Wick G, Dierich MP.
    Immunology; 1988 Oct 15; 65(2):237-41. PubMed ID: 2461345
    [Abstract] [Full Text] [Related]

  • 17. Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies.
    Golay JT, Crawford DH.
    Immunology; 1987 Oct 15; 62(2):279-84. PubMed ID: 2824347
    [Abstract] [Full Text] [Related]

  • 18. Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1.
    Henriquez NV, Floettmann E, Salmon M, Rowe M, Rickinson AB.
    J Immunol; 1999 Mar 15; 162(6):3298-307. PubMed ID: 10092782
    [Abstract] [Full Text] [Related]

  • 19. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.
    Yajima M, Kanda T, Takada K.
    J Virol; 2005 Apr 15; 79(7):4298-307. PubMed ID: 15767430
    [Abstract] [Full Text] [Related]

  • 20. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y, Abe R, Kozono H, Kelly RG, Azuma T, Holers VM.
    J Immunol; 1998 Feb 15; 160(4):1565-72. PubMed ID: 9469411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.